These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 8521773)

  • 1. Amlodipine. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disease.
    Haria M; Wagstaff AJ
    Drugs; 1995 Sep; 50(3):560-86. PubMed ID: 8521773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amlodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiovascular disease.
    Murdoch D; Heel RC
    Drugs; 1991 Mar; 41(3):478-505. PubMed ID: 1711448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amlodipine: a new calcium antagonist.
    Clavijo GA; de Clavijo IV; Weart CW
    Am J Hosp Pharm; 1994 Jan; 51(1):59-68. PubMed ID: 8135260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nisoldipine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of angina pectoris, hypertension and related cardiovascular disorders.
    Friedel HA; Sorkin EM
    Drugs; 1988 Dec; 36(6):682-731. PubMed ID: 3065058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of 1,4-dihydropyridine calcium channel blockers: therapeutic implications.
    Katz AM; Leach NM
    J Clin Pharmacol; 1987 Nov; 27(11):825-34. PubMed ID: 3323259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicardipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in the treatment of angina pectoris, hypertension and related cardiovascular disorders.
    Sorkin EM; Clissold SP
    Drugs; 1987 Apr; 33(4):296-345. PubMed ID: 3297616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Amlodipine].
    Handrock R; Herzig S
    Dtsch Med Wochenschr; 1998 Jan; 123(1-2):19-20. PubMed ID: 9465851
    [No Abstract]   [Full Text] [Related]  

  • 8. Amlodipine: an overview of its pharmacodynamic and pharmacokinetic properties.
    van Zwieten PA
    Clin Cardiol; 1994 Sep; 17(9 Suppl 3):III3-6. PubMed ID: 9156957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Manidipine: a review of its use in hypertension.
    Cheer SM; McClellan K
    Drugs; 2001; 61(12):1777-99. PubMed ID: 11693466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of calcium channel antagonists for cardiovascular disease.
    Yedinak KC
    Am Pharm; 1993 Aug; NS33(8):49-64; quiz 64-6. PubMed ID: 8213473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mibefradil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the management of hypertension and angina pectoris.
    Brogden RN; Markham A
    Drugs; 1997 Nov; 54(5):774-93. PubMed ID: 9360062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of amlodipine and lacidipine on left ventricular diastolic and long axis functions in arterial hypertension and stable angina pectoris.
    Zaliunas R; Jurkevicus R; Zabiela V; Brazdzionyte J
    Acta Cardiol; 2005 Jun; 60(3):239-46. PubMed ID: 15999461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical hemodynamic effects of amlodipine in patients with hypertension associated with angina pectoris].
    Bychko MV
    Lik Sprava; 2004; (1):55-9. PubMed ID: 17051717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial.
    Ruzyllo W; Tendera M; Ford I; Fox KM
    Drugs; 2007; 67(3):393-405. PubMed ID: 17335297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nisoldipine: a new dihydropyridine calcium-channel blocker.
    Mitchell J; Frishman W; Heiman M
    J Clin Pharmacol; 1993 Jan; 33(1):46-52. PubMed ID: 8429113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative study to assess the efficacy and adverse effects of amlodipine and nifedipine retard in patients with stable exertional angina and hypertension].
    Witkowska M; Tracz W; Kubler G; Negrusz-Kawecka M; Hlawaty M; Olszowska M; Salamon P
    Przegl Lek; 1997; 54(5):324-8. PubMed ID: 9380807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An update on the safety of amlodipine.
    Osterloh IH
    J Cardiovasc Pharmacol; 1991; 17 Suppl 1():S65-8. PubMed ID: 16296714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic effects of benidipine in patients with vasospastic angina: comparison with diltiazem and amlodipine.
    Fukumoto Y; Yasuda S; Ito A; Shimokawa H
    J Cardiovasc Pharmacol; 2008 Mar; 51(3):253-7. PubMed ID: 18356689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.
    Jamerson K; Weber MA; Bakris GL; Dahlöf B; Pitt B; Shi V; Hester A; Gupte J; Gatlin M; Velazquez EJ;
    N Engl J Med; 2008 Dec; 359(23):2417-28. PubMed ID: 19052124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of calcium channel blockers in heart failure: focus on recent trials with second-generation dihydropyridines.
    de Vries RJ; van Veldhuisen DJ; Dunselman PH
    Am Heart J; 2000 Feb; 139(2 Pt 1):185-94. PubMed ID: 10650289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.